Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 48

Results For "clinical"

3755 News Found

Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion
Hospitals | May 18, 2026

Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion

Medanta expanded its bed capacity by 20% during the year


WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med
News | May 16, 2026

WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med

The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers


Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer
Clinical Trials | May 15, 2026

Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer

The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents


Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push
News | May 14, 2026

Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push

Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support


Merck to showcase 100+ oncology studies at 2026 ASCO meeting
R&D | May 14, 2026

Merck to showcase 100+ oncology studies at 2026 ASCO meeting

Highlighting KEYTRUDA & expanding cancer pipeline


Wegovy delivers consistent weight loss & heart benefits for women across menopause: Novo Nordisk study
News | May 14, 2026

Wegovy delivers consistent weight loss & heart benefits for women across menopause: Novo Nordisk study

Nearly one in five women worldwide are now living with obesity


Pfizer scores landmark EU approval for  hemophilia drug HYMPAVZI
Drug Approval | May 14, 2026

Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy


Eli Lilly  launches Lormalzi for early Alzheimer’s treatment in India
Biopharma | May 13, 2026

Eli Lilly launches Lormalzi for early Alzheimer’s treatment in India

Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence